USANA Guides FY2026 EPS at $0.76, a 64% Miss That Reshapes the Risk Profile

For investors, USANA’s guidance blowup is a stark reminder that forward estimates can quickly become obsolete. The $0.76 EPS figure implies the company will earn less in the whole of 2026 than many expected it to earn in a single quarter, forcing a complete rethink of fair value. With the stock still sporting a trailing P/E of nearly 49, even a modest re-rating lower could push shares well below the $16.60 floor, making this a high-stakes period for holders.

USANA Health Sciences, a global nutritional supplement company operating a direct-selling model, shocked the market on Tuesday by issuing fiscal 2026 guidance that drastically undershot Wall Street expectations. The company projected full-year earnings per share of just $0.76, a staggering 64% below the consensus estimate of $2.12, and revenue of $910 million, 3.7% short of the $945.1 million analysts had modeled. This grim outlook was released in tandem with second-quarter 2026 results that themselves missed badly: a net loss of $0.07 per share against expectations of a $0.43 profit, on revenue of $223.27 million versus the $235 million consensus. The dual disappointments signal that USANA’s operational challenges are far deeper than many investors had priced in, raising serious questions about the company’s competitive position and the sustainability of its business model.

“

The company projected full-year earnings per share of just $0.76, a staggering 64% below the consensus estimate of $2.12, and revenue of $910 million, 3.7% short of the $945.1 million analysts had modeled.

The guidance shock is particularly jarring because it implies a dramatic deterioration in profitability during the back half of the fiscal year—even if the second half is heavily back-loaded, the implied second-half EPS of approximately $0.83 (to reach the full-year $0.76 after a first-half loss) falls far short of what would be needed to meet the original $2.12 annual target. The revenue guidance, while less catastrophic, still indicates top-line softness that likely reflects ongoing market share erosion in key geographies and waning distributor productivity, consistent with trends that have plagued other multilevel marketers. For context, USANA’s revenue had already been under pressure, and the latest quarterly sales were down significantly from prior-year levels (though exact comparisons aren’t provided in the release).

The immediate market reaction was curiously muted. Shares inched up $0.05 to $22.89 on volume barely above the daily average, suggesting that the guidance was either largely leaked in advance or that investors had already capitulated after a prolonged slide from the 52-week high of $32.32. With a market capitalization of just $422.53 million, the stock trades at a trailing price-to-earnings ratio of 48.70—a multiple that looks absurdly high in light of the new guidance, which would imply a forward P/E north of 30 even if one credits the company with the full $0.76. The PEG ratio of 0.87, often cited as a bullish signal, relies on growth estimates that now appear wholly unreliable. The stock’s beta of 0.73 suggests it has been less volatile than the broad market, but that may merely reflect chronic underperformance rather than stability.

Analyst sentiment has turned decisively cautious. MarketBeat’s consensus rating stands at “Reduce,” with one Sell and one Hold rating contributing to that score. Weiss Ratings reiterated its “Sell (D)” as recently as June 24, 2026, while Zacks Research downgraded the shares from “Strong-Buy” to “Hold” in April. Tellingly, only Wall Street Zen upgraded the stock—from Hold to Buy—on June 20, a contrarian call that now looks ill-timed given the subsequent guidance. The divergence underscores the uncertainty surrounding USANA’s ability to navigate a challenging environment marked by intense competition from both traditional retailers and e-commerce brands, as well as regulatory scrutiny of direct-selling practices in various markets.